Skip to content
Home/Companies/Pharma/Wilson Therapeutics AB

Wilson Therapeutics AB

Pharma·Sweden·Exited 2018·Held 6yr
Entry
2012
Hold
6yr
Exit
2018

Who owns Wilson Therapeutics AB?

Wilson Therapeutics AB is a Swedish Pharma company, now owned by Alexion Pharmaceuticals, which acquired it in 2018 from HealthCap.

Hand-verified · updated 2026-08-18

Open JSON · CC-BY
HealthCap
Investor
HealthCap
HealthCap VI · 2008 · VC

Key facts

HQSweden
SectorPharma
StatusAcquired
Exit Type
Trade Sale
Buyer
Alexion Pharmaceuticals
Exit Year
2018

More from HealthCap VI

Other portfolio companies in the same fund.

GenSight Biologics S.A.
Exited 2016
BiotechFrance· 2015
Glionova AB
Active
BiotechSweden· 2014
Xeris Biopharma Holdings, Inc (Strongbridge)
Exited 2021
PharmaUS· 2014
to Xeris Pharmaceuticals
Nordic Nanovector AS
Exited 2015
BiotechNO· 2013
Oncopeptides AB
Exited 2017
BiotechSE· 2013
Ultragenyx
Exited 2014
BiotechUS· 2011

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Advantice Health
Advantice Health
Active
TA AssociatesUS
Alcala Farma
Active
Advent InternationalSpain
Alvogen
Alvogen
Active
CVC Capital Partners
Anovo
Anovo
Active
ArdianUS

Questions

Who owns Wilson Therapeutics AB?

Wilson Therapeutics AB is now owned by Alexion Pharmaceuticals, which acquired it in 2018 from HealthCap.

When did Alexion Pharmaceuticals acquire Wilson Therapeutics AB?

Alexion Pharmaceuticals acquired Wilson Therapeutics AB in 2018, buying from HealthCap.

Who did Wilson Therapeutics AB sell to?

HealthCap sold Wilson Therapeutics AB to Alexion Pharmaceuticals in 2018 (Trade Sale).

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue